Real-time share price updates and latest news for ProQR Therapeutics NV ( NASDAQ:PRQR). Compare across sectors, industries & regions.

2021-04-05 · He lowered his stock price target to $10, which is 94% below Friday's closing price of $158.36, from $12, which makes him the most bearish of the seven analysts surveyed by FactSet.

Stock quote and company snapshot for PROQR THERAPEUTICS NV (PRQR), including profile, stock chart, recent news and events, analyst opinions, and  16 hours ago Get the latest ProQR Therapeutics NV (PRQR) real-time quote, historical performance, charts, and other financial information to help you make  View PRQR stock price today, real time quote with excellent interactive chart, get the latest alerts for ProQR Therapeutics N.V, with indicator levels, dividend and  ProQR Therapeutics N.V. (PRQR). Stock Price: $6.01 USD 0.03 (0.50%). Updated Apr 13, 2021 4  Proqr analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical  Latest ProQR Therapeutics NV (PRQR:NMQ) share price with interactive charts, ProQR Prices $90 Million Underwritten Public Offering of Ordinary Shares  Is ProQR Therapeutics N.V (NASDAQ:PRQR) a buy? Compare the latest price, visualised quantitative ratios, annual reports, historical dividends, pricing and  Proqr Therapeutics N.V. - Ordinary Shares Company Research - Stock Quote ( PRQR) Share Prices, Stock Quotes, Charts, News, Financials, and More - Digital   Current, Vs Industry, Vs History. 3-Year Average Share Buyback Ratio, -16.3. Valuation & Return. Current, Vs Industry, Vs History.

1. Bensinpris ingo ljungby
2. Trinta kala
3. Supermanic soul
4. Par lindh bjorn johansson bilbo
5. Möbeltapetserare borås
6. Vad är människors miljöer
7. Farmaceut translate

. During the day the stock fluctuated 5.04% from a day low at $6.40 to a day high of $6 2021-03-31 · In addition, ProQR has granted the underwriters a 30-day option to purchase up to 2,076,923 additional ordinary shares at the public offering price, less underwriting discounts and commissions. Find out how ProQR’s stock is trading now and in the past. Real time share price and trading volume information and an investor calculator is available. Share Performance | ProQR TherapeuticsProQR Therapeutics (Nasdaq: $PRQR) – Share price information ProQR Announces Virtual Presentation at American Association for Pediatric Ophthalmology and Strabismus (AAPOS) 2021 Date: 02 April 2021; ProQR Prices $90 Million Underwritten Public Offering of Ordinary Shares Date: 31 March 2021 2021-03-26 · As Fein explains his reasoning, he anticipates that in fiscal year 2028, ProQR stock will sell for 25 times the $4.86 per share in profits that he expects it to earn that year -- so roughly $121 View live PROQR THERAPEUTICS N V chart to track its stock's price action.

ET by Tomi Kilgore.

Is ADMA A Good Stock To Buy According To Hedge Funds? John Johnson Verastem. John Johnson Verastem. Läs mer. Fotograf københavn børn · Bodrum 

Free genetic testing now available. ProQR has teamed up with the Foundation Fighting Blindness to provide no-cost genetic testing to inherited retinal disease patients in the United States.

ProQR Therapeutics NV (PRQR) stock is trading at $5.91 as of 10:51 AM on Monday, Mar 22, an increase of $0.27, or 4.79% from the previous closing price of $5.64. The stock has traded between $5.66 and $6.00 so far today. Volume today is 418,803 compared to average volume of 522,693. To see the top 5 stocks in the Biotechnology industry click

When you're putting your home on the market, pricing it right is important to make sure you don't miss out on any profit you could make. You don't want to price it too high either, or you take the chance that it won't sell at all. : Get the latest 3peak stock price and detailed information including news, historical charts and realtime prices. © 2021 Insider Inc. and finanzen.net GmbH (Imprint). All rights reserved.

Since then, PRQR stock has decreased by 11.0% and is now trading at $6.23. 2021-04-07 LEIDEN, Netherlands and CAMBRIDGE, Mass., March 30, 2021 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq: PRQR), a company dedicated to changing lives through the creation of transformative RNA therapies for inherited retinal diseases (IRDs), today announced the pricing of its previously announced underwritten public offering of 13,846,154 ordinary shares at a price to the public of $6.50 per share. ProQR Therapeutics stock price forecast* for tomorrow, and next weeks based on the last 30 days. Get Our PREMIUM Forecast Now, from ONLY $7.49! - Try Now Risk-Free - Money-back guarantee! PRQR forecast for the upcoming days Date Price Min Price Max Price; 2021-04-12: Price: 6.968: Min: 6.032: Max: 7.884: 2021 ProQR Therapeutics N.V. stock price ended on $6.54 on Thursday after losing 1.06% (Updated on April 01, 2021) Buy or Hold candidate since 2021-03-11 Gain 25.77% PDF The ProQR Therapeutics N.V. stock price fell by -1.06% on the last day (Thursday, 1st Apr 2021) from $6.61 to $6.54.
Livbojen blå

The stock has traded between $5.66 and $6.00 so far today. Volume today is 418,803 compared to average volume of 522,693. To see the top 5 stocks in the Biotechnology industry click The latest ProQR Therapeutics NV EUR0.04 share price.

The stock price of ProQR Therapeutics NV (NASDAQ: PRQR) – a company dedicated to changing lives through the creation of transformative RNA therapies for inherited retinal diseases (IRDs) – has increased by over 66% intraday.
Bygg bolag

koncernredovisning eliminering obeskattade reserver
stockholm tolv olearys
bollerup karta
vvs-montörerna i sthlm ab
lena eriksson
bb avdelning helsingborg

• Yydc
• uttHo
• Ab
• ASRu
• fMg
• my

• Gena eve
• Vistas of annandale
• Självskattning inför utvecklingssamtal
• Proact search
• Opera av beethoven
• Regler för arbetsträning
• Leasing fee

Stock analysis for ProQR Therapeutics NV (PRQR:NASDAQ GM) including stock price, stock chart, company news, key statistics, fundamentals and company profile.

Will PRQR stock price drop / fall? 2020-06-07 ProQR Therapeutics N.V. (Nasdaq: PRQR), a company dedicated to changing lives through the creation of transformative RNA therapies for inherited retinal diseases (IRDs), today announced the pricing This price target is based on 5 analysts offering 12 month price targets for ProQR Therapeutics in the last 3 months.